Interestingly, in the context of the COVID-19 pandemic, it has been observed that Bcl-6+ GC B cells and Bcl-6+ TFH cells are markedly diminished in SARS-CoV-2 infection (54). This evidence concerns the gene BCL6 and COVID-19.